IP Library Granted Patent US 7,262,023
Granted Patent B2
US 7,262,023 · App. 10/625,559 · Granted Aug 28, 2007

Microbiological process for the production of 7-substituted 11-hydroxy steroids, 7,17-substituted 11-Halogen steroids and uses thereof

Assignee: Bayer Schering Pharma AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,262,023
App. No.
10/625,559
Granted
Aug 28, 2007
Kind
B2
Abstract

A novel method of synthesis for the manufacture of upstream products for the production of compounds with general formulas 8, 10, and 12 is described. In this synthesis, compounds with general formula 4,B are produced in a microbiological reaction. The meanings of R 7 , R 10 , R 11 , R 13 , R 17 and R 17′ as well as of the grouping U—V—W—X—Y—Z are indicated in the claims

Claims (28)

1. A microbiological process for the production of a 7α-substituted 11α-hydroxy steroids of formula 4,B

wherein

R 7 is P—Q, wherein P is a C 1 - to C 4 -alkylene, and Q is hydrogen, C 1 - to C 4 -alkyl- or C 1 - to C 4 -fluoroalkyl, and wherein P—Q is bonded via P to the steroid skeleton,

R 10 is either in α- or β-position and is H, CH 3 or CF 3 , and

R 13 is methyl or ethyl,

comprising hydroxylating and oxidizing of a 7α-substituted steroid of formula 3,A,

wherein R 7 , R 10 and R 13 are as indicated above, with use of a microorganism which is Aspergillus sp., Beauveria sp., Glomerella sp., Gnomonia sp., Haplosporella sp. or Rhizopus sp.

2. A process according to claim 1 , wherein the microorganism is Aspergillus awamori, Aspergillus fischeri, Aspergillus malignus, Aspergillus niger, Beauveria bassiana, Glomerella cingulata, Gnomonia cingulata, Haplosporella hesperedica or Rhizopus stolonifer.

3. A microbiolociical process for the production of 7α-substituted 11 α-hydroxy steroid of formula 4,B

wherein

R 7 is P—Q, wherein P is a C 1 - to C 4 -alkylene and Q is hydrogen, a C 1 - to C 4 -alkyl- or C 1 - to C 4 -fluoroalkyl, and wherein P—Q is bonded via P to the steroid skeleton,

R 10 is either in α- or β-position and is H, CH 3 or CF 3 , and R 13 is methyl or ethyl,

comprising hydroxylating of a 7α-substituted steroid of formula 3,A in 11α-position,

wherein R 7 , R 10 and R 13 are as previously indicated, using a first microorganism which is Aspergillus sp., Beauveria sp., Gibberella sp., Glomerella sp., Gnomonia sp., Metarrhizium sp., Nigrospora sp., Rhizopus sp. or Verticillium sp., to form a 7α-substituted 11α-hydroxy steroid of formula C:

wherein R 7 , R 10 and R 13 are as indicated above, and oxidizing the 7α-substituted 11α-hydroxy steroid product of formula C with use of a second microorganism which is Bacillus sp., Mycobacterium sp., Nocardia sp. or Pseudomonas sp.

4. A process according to claim 3 , wherein the first microorganism is Aspergillus malignus, Aspergillus melleus, Aspergillus niger, Aspergillus ochraceus, Beauveria bassiana, Gibberella fujikuroi, Gibberella zeae, Glomerella cingulata, Glomerella fusaroides, Gnomonia cingulata, Metarrhizium anisopliae, Nigrospora sphaerica, Rhizopus oryzae, Rhizopus stolonifer or Verticillium dahliae.

5. A process according to claim 3 , wherein the second microorganism is Bacillus lactimorbus, Bacillus sphaericus, Mycobacterium neoaurum, Mycobacterium smegmatis, Nocardia corallina, Nocardia globerula, Nocardia minima, Nocardia restrictus, Nocardia rubropertincta, Nocardia salmonicolor or Pseudomonas testosteroni.

6. A microbiological process for the production of a 7α-substituted 11α-hydroxy steroids of formula 4,B

wherein

R 7 is P—Q, wherein P is a C 1 - to C 4 -alkylene, and Q is hydrogen, C 1 - to C 4 -alkyl- or C 1 - to C 4 -fluoroalkyl, and wherein P—Q is bonded via P to the steroid skeleton,

R 10 is either in α- or β-position and is H, CH 3 or CF 3 , and

R 13 is methyl or ethyl,

comprising hydroxylating 7α-substituted steroids of formula D:

wherein R 7 , R 10 and R 13 are as indicated above, using a microorganism which is Beauveria sp., Curvularia sp., Gibberella sp., Glomerella sp., Gnomonia sp., Haplosporella sp., Helicostylum sp., Nigrospora sp., or Syncephalastrum sp.

7. A process according to claim 6 , wherein the microorganism is Beauveria bassiana, Curvularia lunata, Gibberella zeae, Glomerella cingulata, Glomerella fusaroides, Gnomonia cingulata, Haplosporella hesperedica, Helicostylum piriformae, Nigrospora sphaerica , or Syncephalastrum racemosum.

8. A microbiological process according to claim 1 , wherein R 7 stands for CH 3 .

9. A microbiological process according to claim 1 , wherein R 10 stands for H.

10. A microbiological process according to claim 1 , wherein R 13 stands for CH 3 .

Assignments (3)
CHANGE OF NAME Recorded Jul 3, 2013
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 030746/0838 →
CHANGE OF NAME Recorded Nov 14, 2007
From: SCHERING AKTIENGESELLSCHAFT
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 020110/0334 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 24, 2004
From: ZORN, LUDWIG; BOHLMANN, ROLF; GALLUS, NORBERT; KUENZER, HERMANN; MUHN, HANS-PETER; NUBBEMEYER, REINHARD
To: SCHERING AG
Reel/Frame 015126/0585 →
Priority Claims (1)
DE 10233723 · Jul 24, 2002 · national
Continuity (2)
Provisional Application 6040295300 · Aug 14, 2002
Related Publication 20050090477A1 · Apr 28, 2005